ArticleJournal of hand surgery global online2025
Obesity as a Risk Factor for Carpal Tunnel Syndrome Independent of Diabetes Mellitus: A Nationwide Study.
Article in Journal of hand surgery global online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tirzepatide Use Is Associated with Reduced Risk of Carpal Tunnel Syndrome in Overweight and Obese Adults.Clinical pharmacology and therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Although the relationship between diabetes mellitus (DM) and carpal tunnel syndrome (CTS) is well documented because of diabetic neuropathic complications, a relationship specific to CTS and obesity has not yet been identified on a population level. The current study seeks to compare CTS prevalence between obese and nonobese patients and examine relationships among obesity, DM, and CTS. Methods: Data used in this study came from Epic Cosmos, a community collaboration of health systems representing over 227,000,000 patient records from over 1,301 hospitals and 28,600 clinics. All patients at least 18 years of age with an encounter between December 2013 and December 2023 were included and grouped based on presence or absence of International Classification of Diseases-10 codes for CTS, obesity, and DM as well as Current Procedural Terminology codes for EMG and nerve conduction studies. Here, 99% confidence intervals were recorded, and odds ratios (OR) were calculated for group comparison using Results: All adult patients with a documented obesity diagnosis showed a near six-fold increase in CTS prevalence compared with nonobese adult patients. When excluding those with a documented DM diagnosis, this relationship was largely maintained with a five-fold increased prevalence in obese adults without DM compared with nonobese adults without DM. Additionally, obese adults without DM had a higher rate of CTS compared to nonobese, diabetic adults. Conclusions: Although DM patients are classically associated with CTS presentation, obesity even without DM may possess a similar or more powerful relationship. Additionally, comorbidity of obesity and DM suggests an additive effect between the two diagnoses on increased CTS prevalence. However, further research must be performed to evaluate the anatomic and pathologic mechanism of this relationship. Type of study/level of evidence: Differential Diagnosis/Symptom Prevalence Study, Level 2b.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.